Updates are available Correction dated 2024-07-17
Click to view Correction: https://doi.org/10.1007/s10072-024-07694-3
-
Authors
Haggiag, Shalom https://orcid.org/0000-0002-5569-4121
Giannelli, Valerio
Prosperini, Luca
Cruciani, Alessandro
Baiocchini, Andrea
Ruggieri, Serena
Pellicelli, Adriano
Gasperini, Claudio
Tortorella, Carla
- License Information
-
More Information
Article History
Received: 8 May 2024
Accepted: 21 May 2024
First Online: 11 June 2024
Change Date: 17 July 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10072-024-07694-3
Declarations
:
: None.
: None.
: SH received honoraria as a speaker or travel grants from Merck Serono, Genzyme, Novartis, BMS Celgene, Roche, and Sandoz. LP received consulting fees and/or speaker honoraria from Biogen, Celgene, Genzyme, Merck-Serono, Novartis, and Teva; travel grants from Biogen, Genzyme, Novartis, and Teva; and research grants from the Italian MS Society (Associazione Italiana Sclerosi Multipla) and Genzyme. AC received travel grants and/or speaking honoraria from Merck, Bristol-Meyer-Squibb, and Sanofi. SR received personal fees and non-financial support from Biogen, Genzyme, Merck-Serono, Novartis, and Teva. VG, AB, and AP have no relevant disclosures. CG received fees as an invited speaker or travel expenses from Biogen, Merck-Serono, Teva, Sanofi, Novartis, and Genzyme. CT received honoraria as a speaker and member of advisory boards from Alexion, Biogen, BMS Celgene, Horizon, Genzyme, Merck, Novartis, and Roche.
: Our institution does not require ethical approval for reporting individual cases or case series.
: The patient described in this case report has provided informed consent for the use of their data for research purposes, ensuring anonymity and confidentiality.
